Drug-tumor sensitivity matching procedure using diffusion chambers in vivo.
作者信息
Cain B F, Calveley S B, Boreham B A, West C, Price N A, Walker D J, Churchouse M J
出版信息
Cancer Chemother Rep. 1974 Mar-Apr;58(2):189-205.
PMID:4857364
Abstract
摘要
相似文献
1
Drug-tumor sensitivity matching procedure using diffusion chambers in vivo.
Cancer Chemother Rep. 1974 Mar-Apr;58(2):189-205.
2
Attempted drug-tumor sensitivity matching using diffusion chamber-cultivated cells.
Cancer Treat Rep. 1978 Dec;62(12):2035-43.
3
Recent results with clinically used antineoplastic drugs and drug combinations in vivo.
Oncology. 1980;37 Suppl 1:34-41. doi: 10.1159/000225495.
4
[Antineoplastic properties of complex compounds of platinum(II)].
Dokl Akad Nauk SSSR. 1976 Oct 21;230(6):1357-9.
5
Further studies on the tumor inhibitory effects of carbobenzoxy derivatives of amino acids.
Isr J Med Sci. 1972 Jan;8(1):29-33.
6
Collateral sensitivity of resistant lines of mouse leukemias L1210 and L5178Y.
Cancer Res. 1972 Apr;32(4):808-12.
7
Antitumor activity of amidoximes (hydroxyurea analogs) in murine tumor systems.
Cancer Res. 1978 May;38(5):1291-5.
8
Cyclophosphamide-adriamycin combination chemotherapy of transplantable murine tumors.
Cancer Res. 1975 Jun;35(6):1568-73.
9
Antitumor activity of 5-formamido-1- D-ribofuranosylthioimidazole-4-carboxamide 2',3',5'-triformate in a variety of animal tumors.
Cancer Chemother Rep. 1971 Jun;55(3):229-31.
10
Modification of transplantability and tumor growth following treatment of L1210 leukemia and TA3Ha cells with macromomycin (NSC-170105).
Cancer Chemother Rep. 1973 Nov-Dec;57(4):501-3.
Zotero 插件